Latest News

The Aerospace And Defense screener focuses on companies that manufacture or provide services to a sector closely linked to global trade, government budgets and shifting security priorities. With investors tracking everything from oil flows in Hormuz to mixed inflation signals across the US, Europe and Asia, there is growing interest in businesses that sit at the intersection of technology, logistics and long-cycle government programs. This article highlights 3 stocks from the Aerospace And...

Caesars Entertainment expands digital footprint with Wabanaki Nations partnership Caesars Entertainment (CZR) is extending its partnership with three Wabanaki Nations to include online casino gaming in Maine, targeting a potential 2026 iGaming launch, subject to regulatory approvals. See our latest analysis for Caesars Entertainment. Caesars Entertainment shares have climbed over recent months, with a 90 day share price return of 16.79% and year to date gain of 28.14%. However, the 5 year...

What Li Auto’s New L8 Launch Could Mean For the Stock Li Auto (NasdaqGS:LI) has rolled out the upgraded Li L8 SUV in China, with deliveries starting this week, putting a fresh product in front of buyers just as the company seeks to broaden its customer base. The new Li L8, offered in Ultra and Livis trims priced at RMB 369,800 and RMB 429,800, introduces improvements in driving range, in house chip technology, and comfort that could influence how investors think about Li Auto’s current...

Healthy high growth potential stocks are in focus as investors weigh AI investment in China, shifting central bank policies and mixed global growth signals. With inflation readings, trade flows and corporate earnings under close watch, many are looking for companies where analysts expect solid earnings growth over the next 3 years and balance sheets that are not stretched. This Healthy high growth potential screener filters for exactly that and highlights stocks that combine earnings growth...

Wave Life Sciences recently initiated the Phase 2a multidose portion of its INLIGHT trial, testing investigational RNA therapy WVE-007 as a monotherapy for individuals with obesity, higher BMI, and cardiometabolic conditions such as type 2 diabetes. The move follows earlier Phase 1 results showing fat loss with muscle preservation and sets up additional Phase 2 studies in 2026 combining WVE-007 with incretins and as a post-incretin maintenance approach, potentially positioning the program...

First time buyers are being squeezed by rising house prices, stubborn rents, and the need to save larger deposits, and that pressure is starting to show up in listed stocks. When more young adults stay in the family home and focus on cash savings instead of big ticket spending, some companies see headwinds while others stand to benefit if those savings eventually turn into mortgage applications and new builds. This article looks at three stocks from the First Time Homebuyer Demand screener...

Microchip Technology (MCHP) is drawing fresh attention after launching the DSA504RT, a space-grade, radiation-tolerant clock generator designed to simplify timing architectures and support reliability requirements in aerospace and defense systems. See our latest analysis for Microchip Technology. The latest product news comes after a sharp pullback, with Microchip Technology’s share price down 11.87% over the past week and 9.21% over the past month. The stock is still showing a 41.82% 90 day...

Strategy Inc.'s flagship STRC preferred stock has fallen sharply, putting fresh attention on its Bitcoin backed dividend structure. The company has started selling Bitcoin to fund preferred dividends, a shift away from its long stated "never sell" approach. Regulators, analysts, critics and class action law firms are increasing scrutiny of the sustainability and risk of Strategy's funding model. The pressure on Strategy Inc. comes after a steep pullback in the stock, with NasdaqGS:MSTR down...

Recent trading in Interface (TILE) has drawn attention, with the stock’s past month return of 20.3% and past 3 months return of 44.5% prompting investors to reassess its valuation and performance drivers. See our latest analysis for Interface. The recent 9.8% 7 day share price return, on top of a 20.3% 1 month share price return and a 70.2% 1 year total shareholder return, points to building momentum around Interface as investors reassess both its recent execution and perceived risk. If...

Take-Two Interactive Software (TTWO) set out full launch details for Grand Theft Auto VI, confirming a November 19 release, premium edition pricing, and an all digital, single-player only rollout that immediately refocused attention on the stock. See our latest analysis for Take-Two Interactive Software. At a share price of $238.53, Take-Two Interactive Software has a 30 day share price return of 9.19% and a 90 day share price return of 25.75%. The 3 year total shareholder return of 62.09%...

Speculation around Berkshire Hathaway’s potential addition to the Dow and its US$10 billion deal for Alphabet shares has put conglomerates back into focus, especially those that already sit at the crossroads of index flows and corporate influence. For investors watching how index committee decisions, citizenship headlines and large crossholdings can reshape demand for blue chip stocks, this is a useful moment to reassess exposure. This article walks through three large, diversified companies...

Recent Share Performance and Business Snapshot Live Oak Bancshares (LOB) has drawn fresh investor attention after recent share price gains, with the stock last closing at $41.40 and showing positive returns over the past week, month and past 3 months. The US based bank holding company, which focuses on small business lending and related services, reports annual revenue of $512.213 million and net income of $121.052 million, supported by its digital banking and advisory platform. See our...

Why Bosideng International Holdings Stock Is In Focus After Full-Year Results Bosideng International Holdings (SEHK:3998) has moved into the spotlight after releasing full-year results to March 31, 2026, reporting sales of CNY 27,349.98 million and net income of CNY 3,994.38 million. See our latest analysis for Bosideng International Holdings. The earnings release appears to have shifted sentiment, with Bosideng International Holdings posting an 8.82% 1 day share price gain to HK$3.95,...

Clarivate (CLVT) is back on investors radar after Mitsubishi Fuso Truck and Bus Corporation selected its IPfolio platform for intellectual property management, putting fresh attention on the companys intellectual property segment. See our latest analysis for Clarivate. The Mitsubishi Fuso IPfolio win comes as Clarivate’s share price has rebounded 7.6% over the last day and 4.4% over the past week. However, the 30 day share price return is down 17.8% and the 1 year total shareholder return is...

In June 2026, RingCentral expanded its AIR Pro platform to bring agentic AI across its RingCX customer engagement suite, adding native AI agents, automated outreach, intelligent handoffs, AI-powered workflow and analytics, RingWEM enhancements, and WhatsApp Voice support, with general availability of key features expected in the second half of 2026. An interesting aspect is that more than 1,700 businesses now use RingCX, with over half already leveraging its AI capabilities, showing early...

OSI Systems stock reaction to new $50 million security services order OSI Systems (OSIS) recently reported that its Security division secured an order of about $50 million from a North American customer to provide maintenance for Rapiscan baggage, cargo and vehicle inspection systems. The contract also includes continued support for the CertScan Platform, highlighting ongoing demand for OSI Systems security technology and related services, and giving investors a fresh data point to assess the...

Affirm Holdings Stock Snapshot After Recent Trading Move Affirm Holdings (AFRM) drew fresh attention after its latest trading session, with the stock closing at $79.49. Investors are weighing how this price, alongside recent return figures, fits into their broader diversification plans. The company operates a payment network that spans point of sale financing, merchant commerce tools, and a consumer app. It serves a wide mix of retailers and brands across several spending categories. See our...

Robust quarterly results put Boot Barn Holdings (BOOT) in focus Boot Barn Holdings (BOOT) is back on investors’ radar after recent results highlighted 6.3% year-on-year same-store sales growth, strong revenue expansion and record fiscal 2026 performance, alongside softer guidance for next quarter EPS. See our latest analysis for Boot Barn Holdings. The recent quarterly beat and record fiscal 2026 results have coincided with a 19.0% 90-day share price return and a 14.9% one-year total...

Scout24 (XTRA:G24) is back in focus after shareholders approved a higher dividend of €1.50 per share for the 2025 financial year, along with a fresh voting rights notification from Morgan Stanley. See our latest analysis for Scout24. At a share price of €72.45, Scout24 has seen a 14.36% 90 day share price return, even though the year to date share price return is down 14.16%, and the 1 year total shareholder return is down 36.15%. The 3 year and 5 year total shareholder returns of 30.80% and...

Camden Property Trust (CPT) recently affirmed a second quarter cash dividend of $1.06 per share. The decision highlights management’s current stance on capital returns as the apartment REIT balances Sunbelt demand and supply headwinds. See our latest analysis for Camden Property Trust. Camden Property Trust’s recent dividend affirmation comes as the share price trades at $116.31, with a 90 day share price return of 19.96% and a 1 year total shareholder return of 6.42%, suggesting momentum has...

Amylyx Pharmaceuticals recently presented past first-in-human Phase 1 LUMINA trial data for its investigational ALS therapy AMX0114 at the 2026 ENCALS meeting in Madrid, reporting that the lowest 12.5 mg dose cohort showed no drug-related serious adverse events and stable key neurodegeneration biomarkers. The early safety profile and FDA Fast Track status of AMX0114 add a new dimension to Amylyx’s neurodegeneration pipeline, potentially enhancing the company’s long-term optionality alongside...

In the first quarter of 2026, Brown Capital Management’s Small Company Fund added XPEL, highlighting its global paint protection film business and proprietary installer software. Recent insider equity grants and tax-withholding share transactions by XPEL’s CEO and CFO underline management’s meaningful ongoing ownership in the company. We’ll now examine how Brown Capital Management’s new position, emphasizing XPEL’s under-penetrated paint protection film market, affects the company’s...

Griffon (GFF) has been drawing attention after its recent trading performance, with the stock last closing at $96.42. Investors are weighing that move against the company’s latest revenue and net income figures. See our latest analysis for Griffon. The recent 0.52% 1 day share price return builds on a 30 day gain of 9.93% and a 90 day rise of 36.73%, while Griffon’s 5 year total shareholder return of 362.14% shows how strong the longer term trend has been. If Griffon’s run has you thinking...

Flex (FLEX) has drawn fresh attention after moving to spin off its Cloud and Power Infrastructure business. The shift is aimed at AI related opportunities, while industrial, energy grid, and commercial transport activities remain in focus. See our latest analysis for Flex. The recent move to spin off Cloud and Power Infrastructure comes after a sharp run in Flex's share price, with the stock up strongly over the past 90 days and delivering a very large 5 year total shareholder return, even...